Earnings call transcript: Amgen Q1 2026 beats EPS forecast, stock dips

robot
Abstract generation in progress
Amgen Inc. (AMGN) reported stronger-than-expected earnings for Q1 2026, with EPS of $5.15 against a forecast of $4.80, and revenue slightly exceeding expectations at $8.62 billion. Despite the beat, the stock dipped 2.43% in after-hours trading, influenced by investors weighing updated guidance and market conditions. The company raised its full-year 2026 revenue guidance and discussed strong performance from key growth drivers and advancements in its pipeline, including MariTide and Olpasiran.
AMGN0.69%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned